Replimune Group Inc
For the period ended Mar 31, 2024. Filed May 16, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed May 16, 2024
REPL$23.28+4.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated statements of cash flows F-
(Amounts in thousands)
| Year Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flows from operating activities: | ||
| Net loss | $(215,794) | $(174,284) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Stock-based compensation expense | 34,125 | 28,131 |
| Depreciation and amortization | 2,655 | 2,447 |
| Net amortization of premiums and discounts on short-term investments | (12,326) | (5,638) |
| Noncash interest expense | 1,161 | 494 |
| Unrealized foreign currency transaction losses | (771) | 5,676 |
| Changes in operating assets and liabilities: | ||
| Research and development incentives receivable | (1,916) | (61) |
| Prepaid expenses and other current assets | (1,778) | (1,059) |
| Operating lease, right-of-use-asset | 615 | 225 |
| Finance lease, right-of-use-asset | 2,428 | 2,428 |
| Accounts payable | (2,794) | 1,981 |
| Accrued expenses and other current liabilities | 9,234 | 11,376 |
| Operating lease liabilities | (620) | (238) |
| Other non-current liabilities | 314 | 472 |
| Net cash used in operating activities | (185,467) | (128,050) |
| Cash flows from investing activities: | ||
| Purchases of property, plant and equipment | (5,662) | (2,270) |
| Purchase of short-term investments | (489,516) | (583,412) |
| Proceeds from sales and maturities of short-term investments | 592,379 | 443,180 |
| Net cash provided by (used in) investing activities | 97,201 | (142,502) |
| Cash flows from financing activities: | ||
| Proceeds from issuance of common stock, net of underwriting fees and discounts | — | 149,854 |
| Proceeds from issuance of prefunded warrants to purchase common stock, net of underwriting fees and discounts | — | 92,778 |
| Proceeds from issuance of common stock through ATM sales, net of offering costs | — | 37,438 |
| Proceeds from long-term debt, net of debt issuance costs | 15,000 | 28,154 |
| Principal payment of finance lease obligation | (476) | (365) |
| Proceeds from exercise of stock options | 1,759 | 3,444 |
| Net cash provided by financing activities | 16,283 | 311,303 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (86) | (109) |
| Net (decrease) increase in cash, cash equivalents and restricted cash | (72,069) | 40,642 |
| Cash, cash equivalents and restricted cash at beginning of period | 148,226 | 107,584 |
| Cash, cash equivalents and restricted cash at end of period | $76,157 | $148,226 |
| Supplemental disclosure of cash flow information: | ||
| Cash paid during the period for interest | 3,044 | $1,066 |
| Cash paid for income taxes | 300 | — |
| Supplemental disclosure of non-cash investing and financing activities: | ||
| Purchases of property and equipment included in accounts payable | $101 | $103 |
| Lease assets obtained in exchange for new operating lease liabilities | $— | $290 |
F - 8
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.